These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37347469)

  • 1. Rates of and Factors Associated With Patient Withdrawal of Consent in Cancer Clinical Trials.
    Hillman SL; Jatoi A; Strand CA; Perlmutter J; George S; Mandrekar SJ
    JAMA Oncol; 2023 Aug; 9(8):1041-1047. PubMed ID: 37347469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Perceived Benefit or Burden of Research Participation With Participants' Withdrawal From Cancer Clinical Trials.
    Ulrich CM; Ratcliffe SJ; Zhou Q; Huang L; Hochheimer C; Gordon T; Knafl K; Miller V; Naylor MD; Schapira MM; Richmond TS; Grady C; Mao JJ
    JAMA Netw Open; 2022 Nov; 5(11):e2244412. PubMed ID: 36449287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse Research Teams and Underrepresented Groups in Clinical Studies.
    Bains A; Osathanugrah P; Sanjiv N; Chiu C; Fiorello MG; Siegel NH; Peeler CE; Distefano AG; Lee HJ; Ness S; Desai MA; Titelbaum JR; Pira T; LaMattina KC; Christiansen SP; Cabral HJ; Subramanian ML
    JAMA Ophthalmol; 2023 Nov; 141(11):1037-1044. PubMed ID: 37856135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Factors Associated With Parental Perceptions of Voluntary Decisions About Child Participation in Leukemia Clinical Trials.
    Aristizabal P; Ma AK; Kumar NV; Perdomo BP; Thornburg CD; Martinez ME; Nodora J
    JAMA Netw Open; 2021 May; 4(5):e219038. PubMed ID: 33944924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical Trials.
    Pugh SL; Rodgers JP; Yeager KA; Chen RC; Movsas B; Bonanni R; Dignam J; Bruner DW
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):950-959. PubMed ID: 32590048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sperm selection with hyaluronic acid improved live birth outcomes among older couples and was connected to sperm DNA quality, potentially affecting all treatment outcomes.
    West R; Coomarasamy A; Frew L; Hutton R; Kirkman-Brown J; Lawlor M; Lewis S; Partanen R; Payne-Dwyer A; Román-Montañana C; Torabi F; Tsagdi S; Miller D
    Hum Reprod; 2022 May; 37(6):1106-1125. PubMed ID: 35459947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social Determinants of Health and Informed Consent Comprehension for Pediatric Cancer Clinical Trials.
    Aristizabal P; Nataraj S; Ma AK; Kumar NV; Perdomo BP; Martinez ME; Nodora J; Liu L; Lee E; Thornburg CD
    JAMA Netw Open; 2023 Dec; 6(12):e2346858. PubMed ID: 38079173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SWAT 84: effects of same-day consent vs delayed consent on the recruitment and retention of trial participants-an observational SWAT.
    Elfghi M; Jordan F; Sultan S; Tawfick W
    Trials; 2023 Oct; 24(1):691. PubMed ID: 37880796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing attrition within clinical trials: The communication of retention and withdrawal within patient information leaflets.
    Kearney A; Rosala-Hallas A; Bacon N; Daykin A; Shaw ARG; Lane AJ; Blazeby JM; Clarke M; Williamson PR; Gamble C
    PLoS One; 2018; 13(10):e0204886. PubMed ID: 30379822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of participants consenting versus declining follow-up for up to 10 years in a randomized clinical trial.
    Sheffet AJ; Voeks JH; Mackey A; Brooks W; Clark WM; Hill MD; Howard VJ; Hughes SE; Tom M; Longbottom ME; Brott TG;
    Clin Trials; 2015 Dec; 12(6):657-63. PubMed ID: 26122922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical Acceptability of Postrandomization Consent in Pragmatic Clinical Trials.
    Miller DG; Kim SYH; Li X; Dickert NW; Flory J; Runge CP; Relton C
    JAMA Netw Open; 2018 Dec; 1(8):e186149. PubMed ID: 30646316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to clinical trials among oncology patients: results of a cross sectional survey.
    Carey M; Boyes AW; Smits R; Bryant J; Waller A; Olver I
    BMC Cancer; 2017 Sep; 17(1):653. PubMed ID: 28923028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in time to notification of enrollment and rates of withdrawal in resuscitation trials conducted under exception from informed consent.
    Nichol G; Zhuang R; Russell R; Holcomb JB; Kudenchuk PJ; Aufderheide TP; Morrison L; Sugarman J; Ornato JP; Callaway CW; Vaillancourt C; Bulger E; Christenson J; Daya MR; Schreiber M; Idris A; Podbielski JM; Sopko G; Wang H; Wade CE; Hoyt D; Weisfeldt ML; May S
    Resuscitation; 2021 Nov; 168():160-166. PubMed ID: 34384820
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.